ND
Nilima Dayanand Rao
About Nilima Dayanand Rao
Data last updated:
Nilima Dayanand Rao is a Managing Director at Remidex Pharma Private Limited (since 2017), Director at Ishaan Labs Private Limited (since 2017) and Director at Sanil Pharmaceuticals Private Limited (since 1995), and holds 1 more current directorship. The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹24.75 Cr; the largest is Remidex Pharma Private Limited at ₹24.55 Cr (FY 2025). Earlier, Nilima Dayanand Rao was a Director at Sachidanand Cassettes Private Limited (from 1995).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Remidex Pharma Private Limited U24231KA1981PTC004260 | Managing Director | 24 Jan 2017 | 1981 | ₹24.55 Cr (FY 2025) | Active |
 Ishaan Labs Private Limited U24233KA1995PTC018262 | Director | 24 Jan 2017 | 1995 | ₹10.5 Lakh (FY 2025) | Active |
| Sanil Pharmaceuticals Private Limited U24239KA1989PTC010426 | Director | 30 Sep 1995 | 1989 | ₹9.5 Lakh (FY 2025) | Active |
| Surima Ventures Llp ACL-6273 | Designated Partner | 27 Jan 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Sachidanand Cassettes Private Limited U85110KA1995PTC019049 | Director | 25 Oct 1995 | 1995 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nilima Dayanand Rao
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ishaan Pejavar Rao | 08262033 | Remidex Pharma Private Limited , Ishaan Labs Private Limited and 2 more | Director |
| Nandan Pejavar Rao | 08262013 | Remidex Pharma Private Limited , Ishaan Labs Private Limited and 2 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nilima Dayanand Rao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nilima Dayanand Rao
Nilima Dayanand Rao currently holds 4 directorships: Remidex Pharma Private Limited (Managing Director, since 24 Jan 2017, revenue ₹24.55 Cr (FY 2025)); Ishaan Labs Private Limited (Director, since 24 Jan 2017, revenue ₹10.5 Lakh (FY 2025)); Sanil Pharmaceuticals Private Limited (Director, since 30 Sep 1995, revenue ₹9.5 Lakh (FY 2025)); Surima Ventures Llp (Designated Partner, since 27 Jan 2025).
Nilima Dayanand Rao was first appointed on 30 Sep 1995 as Director at Sanil Pharmaceuticals Private Limited. The most recent appointment on record is 27 Jan 2025 at Surima Ventures Llp.
The 3 current companies of Nilima Dayanand Rao that report revenue have a combined latest revenue of ₹24.75 Cr: Remidex Pharma Private Limited ₹24.55 Cr (FY 2025); Ishaan Labs Private Limited ₹10.5 Lakh (FY 2025); Sanil Pharmaceuticals Private Limited ₹9.5 Lakh (FY 2025).
Nilima Dayanand Rao held 1 earlier board appointment: Sachidanand Cassettes Private Limited (Director, from 25 Oct 1995).
The current boards of Nilima Dayanand Rao's companies include Ishaan Pejavar Rao (Remidex Pharma Private Limited), Nandan Pejavar Rao (Remidex Pharma Private Limited).